Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | MALT1 | Q9UDY8 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | RBP4 | P02753 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL340412 | 1.00 | ALOX15 (0.45) | ALOX15KDM4EL3MBTL1PDE4BMALT1 | |
| SCHEMBL45109 | 0.87 | MALT1 (0.38) | ALOX15KDM4EPDE4BMALT1ALDH1A1 | |
| SCHEMBL44850 | 0.86 | MALT1 (0.35) | ALOX15KDM4EL3MBTL1MALT1HTT | |
| SCHEMBL44851 | 0.86 | MALT1 (0.35) | ALOX15KDM4EL3MBTL1MALT1HTT | |
| SCHEMBL384694 | 0.82 | ALDH1A1 (0.45) | ALOX15MALT1ALDH1A1RBP4HTT | |
| SCHEMBL23249321 | 0.80 | DHODH (0.45) | ALOX15MALT1ALDH1A1RBP4GAA | |
| SCHEMBL45318 | 0.80 | KMT2A (0.41) | MALT1ALDH1A1RBP4 | |
| SCHEMBL44760 | 0.80 | MALT1 (0.39) | ALOX15KDM4EMALT1ALDH1A1RBP4 | |
| SCHEMBL29504162 | 0.80 | DHODH (0.45) | ALOX15MALT1ALDH1A1RBP4GAA | |
| SCHEMBL951154 | 0.80 | MALT1 (0.34) | MALT1RBP4TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791139-B2 | Anthranilic diamide derivatives | BAYER CROPSCIENCE AG (DE) | 2014-07-29 | — | — | US | disclosed |
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015980-A1 | ANTHRANILIC DIAMIDE DERIVATIVES | DDT, QDPR, ANTXR2 | ALOX15 2578/4885KDM4E 1998/4885L3MBTL1 1767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.